State NM
Clinical Trials in New Mexico
New Mexico is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Mexico and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 62 actively recruiting studies with New Mexico sites out of 62 registered in total. The busiest research areas in New Mexico are Cardiovascular Diseases, Multiple Myeloma, Endometrial Cancer. Leading sponsors running trials in the state include AstraZeneca, SWOG Cancer Research Network, NRG Oncology. By stage, New Mexico trials break down as Phase 1 (1), Phase 2 (18), Phase 3 (26), Phase 4 (1).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Mexico
Frequently Asked Questions — Clinical Trials in New Mexico
How many clinical trials are currently recruiting in New Mexico?
ClinicalMetric currently tracks 62 actively recruiting clinical trials with at least one location in New Mexico. The total number of registered studies—including active but not currently enrolling trials—is 62. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Mexico?
New Mexico hosts clinical trials across a broad range of medical conditions, including Cardiovascular Diseases, Multiple Myeloma, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Mexico serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Mexico?
To join a clinical trial in New Mexico, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Mexico maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Mexico
NCT04920617 Phase 2
Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosp...
Condition
Relapsed Diffuse Large B-cell Lymphoma
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
ImmunoVaccine Technologies, In
NCT05943535 Phase 3
Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progre...
Condition
Progressive Pulmonary Fibrosis
Enrollment
698 pts
Location
United States, Argentina, Australia
Sponsor
United Therapeutics
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05677490 Phase 3
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanc...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
382 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT06775379 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Condition
Major Depressive Disorder
Enrollment
450 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
NCT05512208 Phase 2
Recruiting
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
Condition
Endometrioid Cancer
Enrollment
55 pts
Location
United States
Sponsor
University of Oklahoma
NCT04239573 N/A
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Assoc...
Condition
Pancreatic Neoplasm
Enrollment
770 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06712654 Phase 2
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in...
Condition
Hyperphosphatemia
Enrollment
168 pts
Location
United States, China
Sponsor
R1 Therapeutics
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
NCT02098252 N/A
Recruiting
Treatment of Brain AVMs (TOBAS) Study
Condition
Unruptured Brain Arteriovenous Malformation
Enrollment
1,000 pts
Location
United States, Brazil, Canada
Sponsor
Centre hospitalier de l'Univer
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05467891 Phase 2
Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurr...
Condition
Locoregional Recurrence
Enrollment
200 pts
Location
United States
Sponsor
Oana Danciu
NCT07391774 Phase 3
Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy ...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,978 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06150742 N/A
Recruiting
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Condition
Acute Kidney Injury
Enrollment
70 pts
Location
United States
Sponsor
Talphera, Inc
NCT06318169 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Enrollment
1,350 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
NCT07276542 Phase 2, Phase 3
Recruiting
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Keta...
Condition
Phantom Limb Syndrome With Pain
Enrollment
30 pts
Location
United States
Sponsor
The Ketamine Research Foundati
NCT07623161 Phase 3
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemi...
Condition
Myelofibrosis
Enrollment
324 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT06989112 Phase 3
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegos...
Condition
Endometrial Cancer
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT07662109 Phase 3
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of the Combination of E...
Condition
Type 2 Diabetes Mellitus
Enrollment
2,000 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT05642611 Phase 3
Recruiting
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemo...
Condition
Malignant Solid Neoplasm
Enrollment
777 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07111663 N/A
Recruiting
An Observational Study of Individuals With Isolated Dystonia
Condition
Isolated/Primary Dystonia That Affects More Than One Region of the Body
Enrollment
200 pts
Location
United States
Sponsor
Vima Therapeutics
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT06274801 Phase 3
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EX...
Condition
Pulmonary Arterial Hypertension
Enrollment
330 pts
Location
United States, Argentina, Australia
Sponsor
Gossamer Bio USA, Inc.
NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participant...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
40 pts
Location
United States, Canada
Sponsor
Incyte Corporation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology